Found: 16
Select item for more details and to access through your institution.
Supraagonistic, bispecific single-chain antibody purified from the serum of cloned, transgenic cows induces T-cell-mediated killing of glioblastoma cells in vitro and in vivo.
- Published in:
- International Journal of Cancer, 2005, v. 117, n. 6, p. 1060, doi. 10.1002/ijc.21294
- By:
- Publication type:
- Article
Role of target antigen in bispecific-antibody-mediated killing of human glioblastoma cells: A pre-clinical study.
- Published in:
- International Journal of Cancer, 1999, v. 80, n. 4, p. 612, doi. 10.1002/(SICI)1097-0215(19990209)80:4<612::AID-IJC21>3.0.CO;2-K
- By:
- Publication type:
- Article
Tumor-growth inhibition with bispecific antibody fragments in a syngeneic mouse melanoma model: The role of targeted T-cell co-stimulation via CD28.
- Published in:
- International Journal of Cancer, 1999, v. 80, n. 1, p. 138, doi. 10.1002/(SICI)1097-0215(19990105)80:1<138::AID-IJC25>3.0.CO;2-J
- By:
- Publication type:
- Article
Characterization of a Bispecific FLT3 X CD3 Antibody in an Improved, Recombinant Format for the Treatment of Leukemia.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 4, p. 648, doi. 10.1038/mt.2015.2
- By:
- Publication type:
- Article
Generation and Preclinical Characterization of a Fc-optimized GITR-Ig Fusion Protein for Induction of NK Cell Reactivity Against Leukemia.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 4, p. 877, doi. 10.1038/mt.2013.11
- By:
- Publication type:
- Article
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01490-w
- By:
- Publication type:
- Article
γδ T cell-mediated antibody-dependent cellular cytotoxicity with CD19 antibodies assessed by an impedance-based label-free real-time cytotoxicity assay.
- Published in:
- Frontiers in Immunology, 2014, v. 5, p. 1, doi. 10.3389/fimmu.2014.00618
- By:
- Publication type:
- Article
4-1BB ligand modulates direct and Rituximab-induced NK-cell reactivity in chronic lymphocytic leukemia.
- Published in:
- European Journal of Immunology, 2012, v. 42, n. 3, p. 737, doi. 10.1002/eji.201141920
- By:
- Publication type:
- Article
Stimulus Dependence of the Action of Small-Molecule Inhibitors in the CD3/CD28 Signalling Network.
- Published in:
- ChemMedChem, 2008, v. 3, n. 9, p. 1404, doi. 10.1002/cmdc.200800134
- By:
- Publication type:
- Article
High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a Lu-based CD22-specific radioimmunoconjugate and rituximab.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 3, p. 489, doi. 10.1007/s00259-015-3175-6
- By:
- Publication type:
- Article
A recombinant bispecific single-chain antibody induces targeted, supra-agonistic CD28-stimulation and tumor cell killing.
- Published in:
- European Journal of Immunology, 2003, v. 33, n. 5, p. 1334, doi. 10.1002/eji.200323322
- By:
- Publication type:
- Article
An Fc-Optimized CD133 Antibody for Induction of Natural Killer Cell Reactivity Against Colorectal Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 789, doi. 10.3390/cancers11060789
- By:
- Publication type:
- Article
A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit in vivo leukemia growth.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 7, p. 1935, doi. 10.1002/ijc.32269
- By:
- Publication type:
- Article
An Fc-optimized NKG2D-immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemia.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 5, p. 1073, doi. 10.1002/ijc.29083
- By:
- Publication type:
- Article
Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140471
- By:
- Publication type:
- Article